Market Insights
Factors such as the extensive adoption of genetic engineering by research institutes and pharmaceutical companies, technological advancement in diagnostic techniques, sensory technology that enables rapid analysis, and rising awareness about molecular diagnostic testing are driving the market growth of nucleic acid testing globally.
The report titled “Nucleic Acid Testing Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall nucleic acid testing market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on technology, application, and different geographical regions.
In order to help strategic decision-makers, the report also includes sections on the competitive profiling of the leading players in the global nucleic acid testing market, attractive investment propositions, and market positioning of key manufacturers.
Geographically, the global nucleic acid testing market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- UK.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global nucleic acid testing market. Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global nucleic acid testing market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global nucleic acid testing market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global nucleic acid testing market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on application, the global nucleic acid testing market is segmented as follows:
- Infectious Diseases
- Genetic Disorders
- Cancer
- Forensic Testing
- Others (blood screening, mitochondrial disorders)
Nucleic acid testing, or nucleic acid amplification testing, is generally abbreviated as NAT or NAAT. Variations exist in the genome sequences of every individual, which makes NAT an ideal technique for the identification of different disorders such as cancer, infectious diseases, genetic disorders, and mitochondrial disorders. Factors such as rapid, sensitive, and specific methods compared to the traditional methods of diagnosis are driving the market growth of nucleic acid testing. NAT is widely used to detect and identify organisms for the diagnosis, prognosis, and treatment of diseases. NAT was previously used to screen for HIV and HCV virus; however, it is now used to detect human T-lymphotropic virus, treponema pallidum, hepatitis B virus, West Nile virus, plasmodium, and trypanosomes.
It is observed that, in the base year 2016, infectious diseases held the largest market share. NAT is capable of identifying genotypes and subtypes, determining resistance to particular antibiotics, and identifying viral load. All these factors are influencing the market growth of the infectious disease segment. Some unique factors, such as the identification of fastidious bacteria, bacterial resistance testing, and the determination of bacterial infection after antibiotics, are increasing the demand for NAT in the identification of infectious diseases. In recent years, NAT has been extensively used for the early diagnosis of genetic variations and the prevention of cancer. It is estimated that NAT will play an important role in personalized and predictive medicine in the future to avoid adverse reactions to medicines.
Based on technology, the global nucleic acid testing market is segmented as follows:
- Polymerase chain reaction (PCR)
- Strand displacement amplification (SDA)
- Ligase chain reaction (LCR)
- Transcription-mediated amplification (TMA)
- Others (nucleic acid sequence-based amplification, genome sequencing)
The nucleic acid test (NAT), also known as the nucleic acid amplification test (NAAT), is a molecular technique used as a screening method to detect genetic material such as DNA or RNA. NAT can detect pathogens; it is capable of detecting infectious donations faster than current tests because it detects genetic material rather than antigens or antibodies. Due to its accuracy and specificity, the demand for nucleic acid testing has increased in recent years. Sample extraction, amplification, and target amplicon detection are the major processes involved in NAT.
Nucleic acid amplification is performed by using three methods, such as target amplification systems, probe amplification systems, and signal amplification. It is observed that target amplification methods such as polymerase chain reaction, strand displacement amplification, ligase chain reaction, and transcription-mediated amplification are the most widely used in the market. In the base year 2015, a polymerase chain reaction was observed as the largest revenue-generating segment as it is a lower-cost technique that plays a fundamental role in disease detection, cloning, DNA typing, structural analysis, sequencing, mutation analysis, and mapping.
For the purpose of this study, the nucleic acid testing market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
Nucleic acid testing is a technique that involves the amplification and detection of genetic material such as DNA or RNA. Variations exist in the genome sequences of every individual, which makes NAT an ideal technique for the detection of different disorders, prenatal screening, and carrier screening. Technological advances in diagnostic methods and an increase in the prevalence of infectious and genetic diseases are driving the growth of the NAT market. It is observed that NAT is a widely accepted diagnostic technique in developed countries. Currently, NAT has been adopted in several countries, such as Canada, France, Australia, New Zealand, South Africa, and other countries in Europe and Asia. In the base year 2016, North America was the largest contributor to the global nucleic acid testing market and occupied a significant portion of the global market.
The United States is regarded as North America’s largest revenue-generating market. Factors such as technological advancement, extensive adoption of genetic engineering, and higher investment in R&D activities are driving the market growth of NAT in North America. Asia Pacific is anticipated to show the fastest growth rate during the forecast period. Factors such as improving economic conditions, populous countries, and increasing demand for NAT would drive market growth in the Asia-Pacific region during the forecast period.
